Education

• MD, University of California-San Francisco, San Francisco, CA, 1981
• Surgical Residency, University of California-San Francisco, San Francisco, CA, 1982-1986
• Research Fellow in Vascular Surgery, Brigham and Women’s Hospital, Boston, MA, 1986-1987
• Vascular Fellow, Brigham and Women’s Children’s Hospital, Boston, MA, 1987-1988
• Endovascular Fellow, Cleveland Clinic, Cleveland, OH, 2000

Professional Activities

Dr. Kent has authored or co-authored more than 300 manuscripts and book chapters that have been published in peer-reviewed journals and textbooks on vascular disease. He has held leadership positions in a number of prestigious professional societies, including president of the Society for Vascular Surgery from 2006-2007 and is currently a director in the American Board of Surgery, secretary and treasurer of the Society of Surgical Chairs and Chair, NIH : NHLBI Bioengineering, Techology and Surgical Sciences Study Section. He is regularly invited to speak at local, national, and international scientific meetings on a wide variety of vascular surgery topics. Dr. Kent is a dedicated teacher, devoted to training future vascular surgeons, as well as retraining vascular surgeons in modern minimally invasive catheter techniques.

Clinical Specialties

Dr. Kent is nationally recognized for his experience and leadership in the field of vascular surgery. He is certified by the American Board of Surgery and specializes in all aspects of vascular surgery, including treatment of aortic aneurysms, carotid disease, thoracic outlet syndrome and lower extremity arterial disease. His practice includes endovascular procedures, as well as other minimally invasive techniques.

Dr. Kent provides a wide range of services including Abdominal Aortic Aneurysm (AAA) Repair - Endovascular, Abdominal Aortic Aneurysm (AAA) Repair - Open, Amputation, Angioplasty With Stent Placement, Carotid Endartecotomy, Carotid Stenting, Extended Efforts in Limb Salvage, Peripheral Artery Bypass, Thoracic Aortic Aneursym - Endovascular, Thoracic Aortic Aneursym - Open, and Thoracic Outlet Syndrome Treatment.

Research Interests

Dr. Kent’s NIH-funded research program focuses on the investigation of the molecular and cellular mechanisms underlying vascular disease with the goal of identifying new therapeutic targets for the treatment of vascular diseases. He has a longstanding history as an investigator on industry sponsored clinical trials. As a past recipient of the E.J. Wylie Traveling Fellowship, a prestigious award from the Society for Vascular Surgery, he has been recognized for his academic excellence in clinical and basic science research.

Dr. Kent's Lab

Funding/Grants

• TGF-beta in intimal hyperplasia after vascular bypass
  Funding Agency: National Institutes of Health
  Principal Investigator(s): K. Craig Kent, MD
  More Information
• Vascular Surgery Research Training Program
  Funding Agency: National Institutes of Health
  Principal Investigator(s): K. Craig Kent, MD
  More Information

Recent Publications

• A model for predicting the risk of carotid artery disease.
  Greco G, Egorova NN, Moskowitz AJ, Gelijns AC, Kent KC, Manganaro AJ, Zwolak RM, Riles TS
  Ann. Surg. 2013 Jun; 257(6):1168-73.
  [PubMed ID: 23333880]
  More Information
• Local drug delivery to prevent restenosis.
  Seedial SM, Ghosh S, Saunders RS, Suwanabol PA, Shi X, Liu B, Kent KC
  J. Vasc. Surg. 2013 May; 57(5):1403-14.
  [PubMed ID: 23601595, PMC ID: 3635112]
  More Information
• Preferential secretion of collagen type 3 versus type 1 from adventitial fibroblasts stimulated by TGF-β/Smad3-treated medial smooth muscle cells.
  Goel SA, Guo LW, Shi XD, Kundi R, Sovinski G, Seedial S, Liu B, Kent KC
  Cell. Signal. 2013 Apr; 25(4):955-60.
  [PubMed ID: 23280188, PMC ID: 3595331]
  More Information
• Causes and implications of readmission after abdominal aortic aneurysm repair.
  Greenblatt DY, Greenberg CC, Kind AJ, Havlena JA, Mell MW, Nelson MT, Smith MA, Kent KC
  Ann. Surg. 2012 Oct; 256(4):595-605.
  [PubMed ID: 22964736, PMC ID: 3444679]
  More Information
• Preoperative factors predict mortality after major lower-extremity amputation.
  Nelson MT, Greenblatt DY, Soma G, Rajimanickam V, Greenberg CC, Kent KC
  Surgery 2012 Oct; 152(4):685-94; discussion 694-6.
  [PubMed ID: 23021137]
  More Information
• Mechanisms of post-intervention arterial remodelling.
  Goel SA, Guo LW, Liu B, Kent KC
  Cardiovasc. Res. 2012 Dec 1; 96(3):363-71.
  [PubMed ID: 22918976, PMC ID: 3500049]
  More Information
• Accelerated aneurysmal dilation associated with apoptosis and inflammation in a newly developed calcium phosphate rodent abdominal aortic aneurysm model.
  Yamanouchi D, Morgan S, Stair C, Seedial S, Lengfeld J, Kent KC, Liu B
  J. Vasc. Surg. 2012 Aug; 56(2):455-61.
  [PubMed ID: 22560311, PMC ID: 3408782]
  More Information
• Transforming growth factor-β increases vascular smooth muscle cell proliferation through the Smad3 and extracellular signal-regulated kinase mitogen-activated protein kinases pathways.
  Suwanabol PA, Seedial SM, Shi X, Zhang F, Yamanouchi D, Roenneburg D, Liu B, Kent KC
  J. Vasc. Surg. 2012 Aug; 56(2):446-54.
  [PubMed ID: 22521802, PMC ID: 3408812]
  More Information
• TGF-β and Smad3 modulate PI3K/Akt signaling pathway in vascular smooth muscle cells.
  Suwanabol PA, Seedial SM, Zhang F, Shi X, Si Y, Liu B, Kent KC
  Am. J. Physiol. Heart Circ. Physiol. 2012 Jun 1; 302(11):H2211-9.
  [PubMed ID: 22447946, PMC ID: 3378292]
  More Information
• Protein kinase C-delta mediates adventitial cell migration through regulation of monocyte chemoattractant protein-1 expression in a rat angioplasty model.
  Si Y, Ren J, Wang P, Rateri DL, Daugherty A, Shi XD, Kent KC, Liu B
  Arterioscler. Thromb. Vasc. Biol. 2012 Apr; 32(4):943-54.
  [PubMed ID: 22328773, PMC ID: 3311123]
  More Information